Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

被引：0
作者：
Greg W Mattingly
Richard H Weisler
Joel Young
Ben Adeyi
Bryan Dirks
Thomas Babcock
Robert Lasser
Brian Scheckner
David W Goodman
机构：
[1] St Charles Psychiatric Associates/Midwest Research,Duke University Medical Center
[2] 4801 Weldon Spring Pkwy,undefined
[3] Durham,undefined
[4] NC,undefined
[5] and University of North Carolina at Chapel Hill,undefined
[6] Rochester Center for Behavioral Medicine,undefined
[7] Shire Development LLC,undefined
[8] Formerly of Shire Development LLC,undefined
[9] Johns Hopkins University School of Medicine,undefined
来源：
BMC Psychiatry | / 13卷
关键词：
Lisdexamfetamine dimesylate (LDX); Attention-deficit/hyperactivity disorder (ADHD); Adults; Response; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 47 条
  • [41] Response of peer relations and social activities to treatment with viloxazine extended-release capsules (Qelbree®): A post hoc analysis of four randomized clinical trials of children and adolescents with attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Gomeni, Roberto
    Hull, Joseph T.
    Busse, Gregory D.
    Lujan, Brendan
    Rubin, Jonathan
    Nasser, Azmi
    BRAIN AND BEHAVIOR, 2023, 13 (04):
  • [42] Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: Data from the first 1000 STEP-BD participants
    Nierenberg, AA
    Miyahara, S
    Spencer, T
    Wisniewski, SR
    Otto, MW
    Simon, N
    Pollack, MH
    Ostacher, MJ
    Yan, L
    Siegel, R
    Sachs, GS
    BIOLOGICAL PSYCHIATRY, 2005, 57 (11) : 1467 - 1473
  • [43] Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials
    Wilens, Timothy E.
    Gault, Laura M.
    Childress, Ann
    Kratochvil, Christopher J.
    Bensman, Lindsey
    Hall, Coleen M.
    Olson, Evelyn
    Robieson, Weining Z.
    Garimella, Tushar S.
    Abi-Saab, Walid M.
    Apostol, George
    Saltarelli, Mario D.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (01) : 73 - 84
  • [44] Visual event related potentials and reaction time in normal adults, normal children, and children with attention deficit hyperactivity disorder: Differences in short-term memory processing
    Frank, Y
    Seiden, J
    Napolitano, B
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1996, 88 (1-2) : 109 - 124
  • [45] Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials
    Faraone, Stephen, V
    Gomeni, Roberto
    Hull, Joseph T.
    Busse, Gregory D.
    Melyan, Zare
    Rubin, Jonathan
    Nasser, Azmi
    PEDIATRIC DRUGS, 2021, 23 (06) : 583 - 589
  • [46] Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
    Asherson, Philip
    Johansson, Lena
    Holland, Rachel
    Fahy, Tom
    Forester, Andrew
    Howitt, Sheila
    Lawrie, Stephen
    Strang, John
    Young, Susan
    Landau, Sabine
    Thomson, Lindsay
    TRIALS, 2019, 20 (01)
  • [47] Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials
    Adler, Lenard A.
    Adams, Julie
    Madera-McDonough, Jessica
    Kohegyi, Eva
    Hobart, Mary
    Chang, Denise
    Angelicola, Mark
    McQuade, Robert
    Liebowitz, Michael
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (05) : 429 - 439
12345